ArticleCancer chemotherapy and pharmacology2021

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells.

Jun Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.